 | Up a level |
Grubb, Kendra J; Lisko, John C; O'Hair, Daniel; Merhi, William; Forrest, John K; Mahoney, Paul; Van Mieghem, Nicolas M; Windecker, Stephan; Yakubov, Steven J; Williams, Mathew R; Chetcuti, Stanley J; Deeb, G Michael; Kleiman, Neal S; Althouse, Andrew D; Reardon, Michael J (2024). Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis. JACC. Cardiovascular Interventions, 17(8), pp. 1007-1016. Elsevier 10.1016/j.jcin.2024.01.292
Van Mieghem, Nicolas M; Deeb, G Michael; Søndergaard, Lars; Grube, Eberhard; Windecker, Stephan; Gada, Hemal; Mumtaz, Mubashir; Olsen, Peter S; Heiser, John C; Merhi, William; Kleiman, Neal S; Chetcuti, Stanley J; Gleason, Thomas G; Lee, Joon Sup; Cheng, Wen; Makkar, Raj R; Crestanello, Juan; George, Barry; George, Isaac; Kodali, Susheel; ... (2022). Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial. JAMA cardiology, 7(10), pp. 1000-1008. American Medical Association 10.1001/jamacardio.2022.2695
Yakubov, Steven J; Van Mieghem, Nicolas M; Reardon, Michael J; Serruys, Patrick W; Gada, Hemal; Mumtaz, Mubashir; Deeb, G Michael; Kodali, Susheel; George, Isaac; Windecker, Stephan; Kleiman, Neal; Chetcuti, Stanley J; Sanchez, Carlos; Dauerman, Harold L; Li, Shuzhen; Popma, Jeffrey J (2020). Propensity-Matched Comparison of Evolut-R Transcatheter Aortic Valve Implantation With Surgery in Intermediate-Risk Patients (from the SURTAVI Trial). The American journal of cardiology, 131, pp. 82-90. Elsevier 10.1016/j.amjcard.2020.06.051
